Andreas Gerber
Geschäftsführer bei APEIRON Biologics AG
Aktive Positionen von Andreas Gerber
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Geschäftsführer | 01.06.2021 | - |
Karriereverlauf von Andreas Gerber
Ausbildung von Andreas Gerber
| University of Basel | Doctorate Degree |
| University of St. Gallen | Masters Business Admin |
Statistik
International
| Schweiz | 3 |
| Österreich | 2 |
Operativ
| Chief Operating Officer | 1 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Börse
- Insiders
- Andreas Gerber
- Erfahrung
